In a recent study published in Nature Medicine, researchers demonstrated the use of the foundational model Virchow for computational analysis of pathological reports, prediction of biomarkers, and identification of cells across multiple cancer types. Virchow’s pan-cancer model showed impressive accuracy, often outperforming clinical-grade models.
Deerfield backs $81M round for biotech developing antifungal therapy with less toxicity
Elion Therapeutics, a biotech focused on invasive fungal infections, has raised $81 million in a Series B funding round for its early-stage candidate, it announced
June 18, 2024